Cure-in-India Initiative to boost innovation in Indian healthcare and medical device industry
New Delhi: A Summit on ‘India the Future Global Healthcare Hub’ was held today at PHD House. Moderating a Session in the Summit, Padma Shri Awardee, Dr K K Aggarwal, Hony Secretary General, IMA said that IMA and PHD Chamber of Commerce have co-organized the Panel Discussion to come forward and promote a concept of Cure-in-India.
Once approved by the Govt. of India, any indigenous medical product is of good quality and should be promoted.
No reimbursement should be given for foreign devices for those drugs and devices, which are available from indigenous reliable sources.
The Govt. should not allow price variation in drugs of more than 10%. During epidemics, there should be a cap on pricing of medical facilities.
The cost of treatment should be transparent and there should be no hidden charges.
The Panel Discussion was organized by PHD Chamber of Commerce to promote medical tourism in India. The panelists included Dr Himangi Bhardwaj, Dr Harsh Wardhan, Mr Nitin Mahajan, Dr Harvinder Popli and Mr Pradeep Multani.